Retraction Retracted : Silymarin Accelerates Liver Regeneration after Partial Hepatectomy Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine has retracted the article titled “Silymarin Accelerates Liver Regeneration a er Partial Hepatectomy” [1]. e article was found to contain images with the following concerns: ere are irregularities in the background in Figures 1(a) and 1(b); the tubulin controls in Figures 1(a) and 1(b) are the same; Figure 3(b), Cyclin B (72 hrs) is the same as Figure 6(b), TGF beta1 (24 hrs); Figure 5(c), the lanes in the TGF-alpha rows at 6 hours and 72 hours do not align. e authors provided corrected gures, which are available as Supplementary Materials, but could not provide the underlying blots.

[1]  A. Dehpour,et al.  Possible involvement of nitric oxide in antidepressant-like effect of silymarin in male mice , 2015, Pharmaceutical biology.

[2]  H. M. Kutlu,et al.  A comparative study on the therapeutic effects of silymarin and silymarin-loaded solid lipid nanoparticles on D-GaIN/TNF-α-induced liver damage in Balb/c mice. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  M. Tsironi,et al.  Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy , 2014, BMC Gastroenterology.

[4]  I. Vlachos,et al.  Liver regeneration: immunohistochemichal study of intrinsic hepatic innervation after partial hepatectomy in rats , 2014, BMC Gastroenterology.

[5]  Y. Liu,et al.  Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. , 2014, European journal of pharmacology.

[6]  S. Hessenberger,et al.  Milk Thistle Extract and Silymarin Inhibit Lipopolysaccharide Induced Lamellar Separation of Hoof Explants in Vitro , 2014, Toxins.

[7]  N. Udupa,et al.  Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells , 2014, Pharmacological reports : PR.

[8]  A. Abdel-Naim,et al.  Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  Qingnian Xu,et al.  Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials , 2014, BioMed research international.

[10]  F. Tsai,et al.  The Effect of Elephantopus scaber L. on Liver Regeneration after Partial Hepatectomy , 2013, Evidence-based complementary and alternative medicine : eCAM.

[11]  S. Thorgeirsson,et al.  Hepatocyte growth factor/c‐met signaling is required for stem‐cell–mediated liver regeneration in mice , 2012, Hepatology.

[12]  K. Kuo,et al.  The Activation of MEK/ERK Signaling Pathway by Bone Morphogenetic Protein 4 to Increase Hepatocellular Carcinoma Cell Proliferation and Migration , 2012, Molecular Cancer Research.

[13]  O. Hammam,et al.  Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis , 2012, Parasites & Vectors.

[14]  G. Ferbeyre,et al.  SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes. , 2011, Journal of hepatology.

[15]  K. Ahmed,et al.  The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats , 2011, Cancer Cell International.

[16]  S. Katiyar,et al.  Silymarin Targets β-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells , 2011, PloS one.

[17]  Hyoung‐Chin Kim,et al.  Vitamin D3 up-regulated protein 1 deficiency accelerates liver regeneration after partial hepatectomy in mice. , 2011, Journal of hepatology.

[18]  C. Loguercio,et al.  Silybin and the liver: from basic research to clinical practice. , 2011, World journal of gastroenterology.

[19]  H. Baba,et al.  Glycine Pretreatment Ameliorates Liver Injury After Partial Hepatectomy in the Rat , 2010, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[20]  R. Agarwal,et al.  Multitargeted therapy of cancer by silymarin. , 2008, Cancer letters.

[21]  N. Okumura,et al.  Cell Surface-Bound Plasminogen Regulates Hepatocyte Proliferation Through a uPA-Dependent Mechanism , 2007, Bioscience, biotechnology, and biochemistry.

[22]  S. K. Pandian,et al.  Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes. , 2007, Basic & clinical pharmacology & toxicology.

[23]  J. Degen,et al.  Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor , 2006, BMC gastroenterology.

[24]  C. Girish,et al.  Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. , 2006, The Indian journal of medical research.

[25]  J. Armendáriz-Borunda,et al.  Urokinase‐type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down‐regulation and up‐regulation of MMPs, HGF and VEGF , 2006, The journal of gene medicine.

[26]  T. Ikejima,et al.  The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis. , 2006, International immunopharmacology.

[27]  P. Steinberg,et al.  Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. , 2003, Biochemical and biophysical research communications.

[28]  D. Carrier,et al.  Extraction of nutraceuticals from milk thistle , 2003, Applied biochemistry and biotechnology.

[29]  N. Fausto,et al.  Role of growth factors and cytokines in hepatic regeneration , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  G. Park,et al.  Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. , 2015, International immunopharmacology.

[31]  J. Féher,et al.  Silymarin in the prevention and treatment of liver diseases and primary liver cancer. , 2012, Current pharmaceutical biotechnology.

[32]  F. Burczynski,et al.  Silymarin and hepatoprotection. , 2012, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[33]  R. Saller,et al.  The Use of Silymarin in the Treatment of Liver Diseases , 2012, Drugs.

[34]  Abigail S. Engelberth,et al.  Extraction of Co-Products from Biomass: Example of Thermal Degradation of Silymarin Compounds in Subcritical Water , 2009 .

[35]  G. Michalopoulos,et al.  Liver regeneration. , 2005, Advances in biochemical engineering/biotechnology.

[36]  H. Tilg,et al.  Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders , 2001 .